Insufflation Devices Market Share, Size, Growth and Forecast Report, 2022 to 2030

Insufflation Devices Market Overview:

Reports and Insights predicts that the global insufflation devices market is expected to grow at a CAGR of 6.4% during the forecast period from 2022 to 2030. Furthermore, the total value of the global insufflation devices market is slated to reach US$ 4.0 Bn by 2030, rising from US$ 2.4 Bn in 2022.

The need for insufflation devices is being driven by people's changing lifestyles, escalating health issues, and the procedures that go along with them.

Laparoscopic surgery, heart surgery, and bariatric surgery, among other surgical procedures, all require insufflation equipment. Insufflation devices assist in maintaining the pneumoperitoneum during bariatric surgery and lessen clinical consequences for the patient. They aid in preserving ideal abdominal pressure conditions, cutting down on operating time and minimizing CO2 pneumoperitoneum problems.

This market study on the global insufflation devices market aims to cover market dynamics such as market drivers, challenges/restraints, and opportunities for the market players. It will also cover market segmentation outlook, insufflation devices market trend, regional outlook, Insufflation devices market size, and market share, as well as industry and product insights, SWOT analysis, Porter's five force analysis, PESTEL analysis, heat map analysis, market forecast, and the major players operating in the insufflation devices market.

Scope of the Report:

Report Metric	Report Details
Market size available for the years	2022-2030
Base year	2021
Forecast Period	2022-2030
Segments Covered	By Application, By End-Use, and By Region
Regions Covered	North America, Latin America, Europe, Asia Pacific, Middle East, and Africa
Key Players	B. Braun Melsungen, BD, CONMED, Fujifilm, Karl Storz, Medtronic, Olympus, Richard Wolf, Smith & Nephew, Steris, Stryker

Insufflation Devices Market Drivers: Predominance of Obesity

Because of innovations in surgical technology, a spike in surgical procedures, and an upsurge in uterine fibroids, obesity, and cardiac conditions around the world, there is a growing demand for insufflation devices. One of the main factors driving the market expansion is the predominance of obesity brought on by sedentary lifestyles and a rise in the consumption of foods that are high in sugar and fat. For instance, the prevalence of obesity in the United States has increased, going from 30.5% in 2000 to 41.9% in 2022.

During the forecast period, the market is anticipated to be driven by the use of insufflation devices in cardiac surgery to prevent postoperative consequences such as brain damage, myocardial dysfunction, and dysrhythmias.

As insufflation devices are used in bariatric surgery, one important market driver is the rapid spread of obese patients with a BMI of 35 to 39 and certain major health issues, such as type 2 diabetes, sleep apnea, and high blood pressure.

Insufflation Devices Market Restraints: Problems associated with gas insufflation

The Insufflation Devices sector's primary adoption trends are examined in the study, along with any problems that might prevent the industry from expanding. For the planning and design of products, and hazards resulting from gas insufflation these components are essential. These elements are necessary for product planning, design, and dangers from gas insufflation. This research thoroughly examines the advancements and difficulties facing the insufflation devices business.

Insufflation Devices Market Opportunities: Market share for insufflation devices is anticipated to be dominated by the laparoscopic surgery segment

Over the forecast period, the laparoscopic surgery segment is expected to expand rapidly. Due to their advantages, laparoscopic treatments are expected to become more commonplace globally, which will lead to an increase in insufflation equipment. High-risk patients, such as the elderly, obese, and those with underlying conditions like cardiovascular and pulmonary issues, frequently have laparoscopic surgery.

Globally, more laparoscopic surgical procedures, including cholecystectomy, hernia repair, laparoscopic splenectomy, and hepatectomy, are being used, which is driving the growth of this market segment. Reduced postoperative pain, better cosmetic outcomes, more patient satisfaction, and a shorter hospital stay are some benefits of laparoscopic surgery. The number of laparoscopic emergency procedures has also increased. These factors are anticipated to advance the market because insufflation devices are frequently used in laparoscopic surgeries, consequently promoting market expansion.

Insufflation Devices Market, by Application Outlook:

Based on the Application, the global insufflation devices market is segmented into; Bariatric Surgery, Cardiac Surgery, Laparoscopic Surgery, and Other Surgeries.

Insufflation Devices Market, by End-Use Outlook:

Based on the End-Use, the global insufflation devices market is segmented into; Ambulatory Surgical Centers, Clinics, and Hospitals.

Insufflation Devices Market, by Regional Outlook:

North America dominated the industry and is predicted to rise significantly over the coming years. Laparoscopic treatments like hysterectomy and cholecystectomy are becoming more common, this is what is driving the growth of this regional market.

Over the projection period, it is anticipated that the Asia Pacific market will develop the fastest. As a result of their low-cost structure, worldwide market businesses are increasingly favoring clinical trials, which is a high-impact contributing driver for the market in the Asia Pacific region. Growing patient acceptance of outpatient surgery and increased knowledge of minimally invasive procedures are anticipated to drive market expansion in this area.

Contemporary Developments in the Insufflation Devices Market:

The Nocira hand-held device was given the breakthrough designation by the US Food and Drug Administration (FDA) in April 2022 to treat acute migraine in patients who were 18 years of age or older.

The United States Food and Drug Administration (FDA) granted Palliare 510(k) permission in July 2021 to expand the use of its EVA15 insufflation technology in endoscopic surgery. With this approval, laparoscopic surgery can now be expanded to include endoscopic and endoluminal procedures using the EVA15 constant pressure insufflation technology.